Opendata, web and dolomites

Symptoma SIGNED

Symptoma, Better Diagnosis for Patients with Rare and Complex Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Symptoma project word cloud

Explore the words cloud of the Symptoma project. It provides you a very rough idea of what is the project "Symptoma" about.

probability    right    pushing    errors    spot    shown    446    solving    overwhelm    health    err    sorted    dealing    doctors    barriers    globally    satisfied    search    don    enter    reducing    leaves    questions    symptoma    harm    unacceptable    matching    blind    free    societal    delivering    devastating    learning    20k    care    competitors    paradigm    outdone    companies    advantage    bar    ranging    wait    40    million    lives    technological    capitalize       30    budgets    list    willingness    quality    persist    total    com    decision    medicine    mission    inaccurate    rare    accuracy    asking    first    pay    diseases    causes    decades    human    cognitive    language    time    billion    intelligence    attain    diagnostic    settings    750    pilot    demand    wasted    spent    healthcare    profit    diagnosis    overcoming    deep    had    misdiagnoses    delayed    customers    opportunity    counteracting    business    diagnoses    receive    proceeded    competitive    solution    continue    10    deaths    patient    suffer    unmet    tools    misdiagnosis    rate    cognitively    patients    symptoms    demonstrated    22    save    engine   

Project "Symptoma" data sheet

The following table provides information about the project.

Coordinator
SYMPTOMA GMBH 

Organization address
address: NEUHOFEN 5
city: ATTERSEE
postcode: 4864
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website https://www.symptoma.com
 Total cost 2˙282˙000 €
 EC max contribution 1˙597˙400 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-09-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SYMPTOMA GMBH AT (ATTERSEE) coordinator 1˙597˙400.00

Map

 Project objective

'OUR MISSION is to save 1.5 million lives globally each year by delivering the right diagnosis. SOCIETAL PROBLEM: To err is human. But in medicine, errors cost lives. 'The delivery of health care has proceeded for decades with a blind spot: Diagnostic errors - inaccurate or delayed diagnoses - persist throughout all settings of care and continue to harm an unacceptable number of patients.' - Institute of Medicine. Studies have shown a devastating rate of misdiagnoses ranging from 10 to 40%. Diagnostic errors cause 10% of patient deaths. 20k diseases cognitively overwhelm doctors. Only 3% of doctors are satisfied with existing research tools. Misdiagnoses account for €446 billion in wasted costs in the EU and $750 billion in the US. Solving misdiagnosis could free up 30% of total healthcare budgets globally. Patients with rare diseases suffer most. 22 of 30 million patients with rare diseases in the EU don’t have their diagnosis yet, and 8 million had to wait 10 years in average. This leaves doctors and patients with a high unmet need. SOLUTION: Symptoma.com is a free search engine for diseases. Users enter symptoms and receive a list of matching causes – sorted by probability. COMPETITIVE ADVANTAGE: Symptoma’s diagnostic accuracy has outdone all competitors’ raising the bar for this field as first and only viable solution. We have demonstrated (1) technological success, (2) high demand, and (3) willingness to pay for our solution operating at a profit with pilot customers. OUR GOAL is to improve diagnostic quality while reducing cost and time spent. We will attain this goal by pushing Symptoma to the next level by (deep) learning from search behaviour, asking questions (cognitive intelligence), and overcoming language barriers. This project is the first step towards a new paradigm of diagnostic decision making. We will fully capitalize on the business opportunity counteracting misdiagnoses for companies dealing with rare diseases.'

 Deliverables

List of deliverables.
D2.2 Release question sequences derived from deep learning algorithms. Demonstrators, pilots, prototypes 2020-01-14 16:40:45

Take a look to the deliverables list in detail:  detailed list of Symptoma deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 DGIM
Querdenker-Preis
published pages: 1085-1085, ISSN: 0012-0472, DOI: 10.1055/a-0954-8989
DMW - Deutsche Medizinische Wochenschrift 144/15 2019-11-22
2019 J. Nateqi, S. Lin, H. Krobath, S. Gruarin, T. Lutz, T. Dvorak, A. Gruschina, R. Ortner
Vom Symptom zur Diagnose – Tauglichkeit von Symptom-Checkern
published pages: 334-342, ISSN: 0017-6192, DOI: 10.1007/s00106-019-0666-y
HNO 67/5 2019-11-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SYMPTOMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SYMPTOMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More